Pharmacogenetics and the concept of individualized medicine. - Wikidata - awgldk - TriplyDB

Pharmacogenetics and the concept of individualized medicine.

Pharmacogenetics and the concept of individualized medicine.

http://www.wikidata.org/entity/Q34562770

about

Review of Medicinal Remedies on Hand Eczema Based on Iranian Traditional Medicine: A Narrative Review Article Estrogen biology: new insights into GPER function and clinical opportunities Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry.Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?Screening for 392 polymorphisms in 141 pharmacogenes.Theranostics: A treasured tailor for tomorrow.More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes.Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach.Beliefs and attitudes towards participating in genetic research - a population based cross-sectional study.Silent SNPs: impact on gene function and phenotype.Chronopharmaceutical drug delivery systems: Hurdles, hype or hope?Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics.Valproate, thalidomide and ethyl alcohol alter the migration of HTR-8/SVneo cells Pharmacogenomic technologies: a necessary "luxury" for better global public health?The obesity-risk variant of FTO is inversely related with the So-Eum constitutional type: genome-wide association and replication analyses Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer Personalizing medicine with clinical pharmacogenetics Rheonix CARD(®) Technology: An Innovative and Fully Automated Molecular Diagnostic Device Digital DNA detection based on a compact optofluidic laser with ultra-low sample consumption.gammaMAXT: a fast multiple-testing correction algorithm.Pharmacogenomics of preterm birth prevention and treatment.Tissue detection of biomolecular predictors in breast cancer.Pharmacogenomics and nutrigenomics: synergies and differences.Take a look inside your eye Time-resolved metabolomics analysis of individual differences during the early stage of lipopolysaccharide-treated rats.Iloperidone: a new option for the treatment of schizophrenia.Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.Ontogeny and drug metabolism in newborns.Pharmacogenomics of opioids and perioperative pain management.Cytochrome P450 pharmacogenetics in African populations.Application of capillary electrophoresis for the early diagnosis of cancer.Diabetes and related remedies in medieval Persian medicine.Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience.Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs.Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.

P2860

Q28066169-C203B002-04B7-4BAC-BB93-7D8A4CFB9EB0 Q28307726-4789C9C5-4740-4625-90CD-86A69795F8C3 Q28546915-101DA914-E2C0-4ADC-8EAD-CD430C48D8A0 Q33547147-D9311D7E-42BA-4619-9321-D07BA139B0EF Q33570878-3EC97FEF-EC2C-41F9-A359-5D809267BED2 Q33613526-92742F1A-C437-4B6C-9526-CE7EA746990E Q33626990-8E8D2714-DA90-4019-A655-1DC42BFCBF59 Q33733501-C5B85AC6-82B7-4A04-93AA-CD64A72B0208 Q34147384-C094B16F-A489-496A-826C-200213117712 Q34156619-F1663D6D-F6EF-4CA2-AE5D-14A613580949 Q34316256-5EF44C24-453F-4225-8B65-0F8B3F3A6539 Q34539092-B0DD9054-CD1D-4B88-8850-193995C49B95 Q34578968-2254573E-95D3-4903-853C-32E6D67EBCEB Q34666876-BA8B3105-74EC-4FFD-B83D-ED5BC9B97BE0 Q34730212-649C9A4B-9D0B-4240-A568-930298512419 Q34981527-F8853853-DB87-47E4-A589-E6195BBC1826 Q35069302-6C0FF88D-EC1D-487D-9CFB-2C6668428253 Q35219458-8A2793DC-5E17-4588-AAC1-BD9E7E3B1013 Q35608018-0BDF09B1-B307-4499-9C02-1BCF19ED1E8A Q35742555-1BE07701-88C2-465D-959E-979BB7EBFA5D Q35791989-0964E3BE-D6CE-4881-83AE-4D1799D334CB Q36059904-B3F5957F-034A-4839-8614-AAB964ABE2A9 Q36199102-DD68AB41-A0B2-4C59-8DCF-A8636517FDC3 Q36304247-6DCF7A80-05A0-46E9-B2F6-85A16B3D9367 Q36510414-5E938A98-5A28-45F5-AF8D-4BAF4FFE11AA Q36573836-984229FD-997D-4760-9744-FA1655C112E0 Q36703598-2C4FE0D8-8496-40D0-AE38-B69A0082D5CA Q37051924-54695E31-0E48-42D3-93A1-822B061C5B08 Q37303539-F181E469-ADF5-4899-AD4B-4A347CE47904 Q37641995-243E94A5-D15F-4E0D-92C8-46607C8E5A2E Q37706612-290B10F8-D5B5-4E98-9AF9-95354C657786 Q38041608-21B203B0-E4EB-48F3-9F6B-99F3D5AEDA5C Q38061498-E6DBAABB-271D-4AD4-A716-DF667041A5C1 Q38099372-A5977769-F684-45A7-ABD1-08602C33CE82 Q38199367-021A0D76-5B23-4645-8E66-8CD018969274 Q38205223-A38DC946-4B12-4ADE-BB33-B77C6BE9D6E3 Q38404777-B9E1FDF2-13F0-4958-A15B-90045322281D Q39968946-0EC53987-80DE-45AA-9620-442D849F6045 Q40004108-FFF3EAAE-B61E-48BC-8511-573B3DEA140D Q41294047-34A3C99F-ACA9-4B4C-A8B5-A7255F3EDA8A

P2860

Pharmacogenetics and the concept of individualized medicine.

http://www.wikidata.org/entity/Q34562770

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pharmacogenetics and the concept of individualized medicine.

@ast

Pharmacogenetics and the concept of individualized medicine.

@en

Pharmacogenetics and the concept of individualized medicine.

@nl

type

label

Pharmacogenetics and the concept of individualized medicine.

@ast

Pharmacogenetics and the concept of individualized medicine.

@en

Pharmacogenetics and the concept of individualized medicine.

@nl

prefLabel

Pharmacogenetics and the concept of individualized medicine.

@ast

Pharmacogenetics and the concept of individualized medicine.

@en

Pharmacogenetics and the concept of individualized medicine.

@nl

P1433

Q34562770-BC924F11-B0E3-4A1C-A3ED-47C177A06236

P1476

Q34562770-7B968AE9-5F56-4CA8-9679-CCAF4FC407A0

P2093

Q34562770-8978836E-E786-492B-9161-83CB3BAB8839

P2860

Q34562770-05A54B40-E965-49D2-86A5-3A4AA1537BA6

Q34562770-0C881E24-9A76-404B-A6CC-1BD105608BF7

Q34562770-0DD7B01D-5A2F-46CD-B744-6D7B15BA4DC4

Q34562770-0F04CA92-F3FD-4645-AFF5-3B2655941204

Q34562770-0F1006CC-F19D-4D04-848F-1B385AC2315D

Q34562770-0F13E971-C8A8-4F04-A79C-331379CE2F28

Q34562770-15830D4B-B18B-4A33-B80A-B10FE98868C0

Q34562770-17873496-E8A4-483B-90BE-A69864D317CA

Q34562770-1B8722EE-7A68-4A4B-A6D7-D56462204245

Q34562770-233E2655-7820-4FC4-98B2-FC0B92B4DE74

P2888

Q34562770-1B7675BD-C721-4A24-BFEA-2CECCD126995

P304

Q34562770-D6681B58-BA8C-4FDC-B70F-43A7D7BBB7E4

P31

Q34562770-4B9FE2E4-00B2-48AF-AC30-2A2C884F424D

P356

Q34562770-AD2B4825-1F81-484B-AED5-F80128ADB919

P433

Q34562770-C624E821-A712-4020-89C8-4C55E32F9860

P478

Q34562770-E2A7406F-6D63-4125-9D08-EA5552465DEA

P577

Q34562770-A898A539-8074-410C-83EB-2EB418F01A2F

P5875

Q34562770-77E51B51-1666-4B5D-809E-812874551E64

P6179

Q34562770-9A373FE0-20C0-4882-896E-E0FF84D64365

P698

Q34562770-274AC009-97EE-4BEC-A087-B759F42A0F7F

P356

P1433

The Pharmacogenomics Journal

P1476

Pharmacogenetics and the concept of individualized medicine.

@en

P2093

Shastry BS

http://www.w3.org/2001/XMLSchema#string

P2860

Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans

Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.

On the probability that a novel variant is a disease-causing mutation.

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.

Molecular basis of ethnic differences in drug disposition and response.

Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.

P2888

P304

16-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.TPJ.6500338

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7466823

http://www.w3.org/2001/XMLSchema#string

P6179

1008330483

http://www.w3.org/2001/XMLSchema#string

P698

16302022

http://www.w3.org/2001/XMLSchema#string